The pathophysiology of trigeminal neuralgia: a molecular review

J Neurosurg. 2023 Mar 31;139(5):1471-1479. doi: 10.3171/2023.2.JNS23274. Print 2023 Nov 1.

Abstract

Objective: The goal of this study was to provide a comprehensive overview of the current understanding of molecular and genetic mechanisms underlying the pathophysiology of trigeminal neuralgia (TN).

Methods: The authors searched PubMed systematically for primary research literature investigating specific molecular mechanisms from samples derived from patients with TN. The genes/molecules of interest from the selected literature were then cross-referenced with corresponding studies in animal models of TN.

Results: From approximately 345 articles, a total of 12 articles were selected and included in the review, focusing on ionotropic channel expressivity and mutations, reactive oxygen species expressivity, inflammatory marker expressivity, and microRNA expressivity. Of the 12 included articles, only 4 had studies completed in other animal models regarding the corresponding TN mechanism found in humans.

Conclusions: The current literature does not suggest a conclusive disease mechanism for TN in humans. In addition to neurovascular conflict/compression of the trigeminal nerve, recent studies have indicated that TN may be linked to inflammatory and reactive oxygen species signaling as well. Recent genetic studies in patients with TN have yet to be investigated further in animal models.

Keywords: NRF2; TRPA1; neuroinflammation; pain; reactive oxygen species; trigeminal ganglion; trigeminal neuralgia.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Models, Animal
  • Reactive Oxygen Species
  • Time Factors
  • Trigeminal Nerve
  • Trigeminal Neuralgia* / genetics

Substances

  • Reactive Oxygen Species